New Hope for Patients. . .

CLINICAL TRIALS

With centers located in the United States, Spain, China and Taiwan, START conducts the world’s largest Phase I medical oncology program. Today, more than 50 percent of cancer patients can be cured with conventional treatments – that is, therapies with a proven response rate. However, there are many patients who do not respond to standard treatment and may be eligible for participation in our Phase I clinical trials program.

CLINICAL RESEARCH

START Taipei consists of a team of highly trained physicians and staff with extensive experience in Phase I clinical trials research and who are nationally recognized as thought leaders in cancer research and drug development.

Innovative Technology

START Taipei directs clinical trials of novel anticancer agents using a high quality and innovative information technology infrastructure to ensure accurate and rapid clinical trials in a setting that emphasizes personalized and compassionate clinical care.

New Hope for a Cure

Meet our Physicians

Dr. Her-Shyong Shiah

Dr. Her-Shyong Shiah

Director of Clinical Research

read full bio

Dr. Wei-Hong (Jack) Cheng

Dr. Wei-Hong (Jack) Cheng

Clinical Investigator

read full bio

Start Taipei

Address goes here

Contact Us

 

Irene Tsai  886-965-562-838

 

Office: No. 252, Wu-Hsing St,. Xinyi Dist., Taipei 11031, Taiwan, (R.O.C.)
Taipei Medical University Hospital Medical Building No2 , 6F., 26 ward.
TEL: +886-2-2737-2181 ext:1663

Company: 1F., No.2-1, Ln. 284, Wuxing St., Xinyi Dist., Taipei City 110, Taiwan (R.O.C.)
TEL: +886-2-2736-1661 ext:2090

9 + 10 =